Pharmaceutical Translation Services Trusted by Attorneys
Professional pharmaceutical translation services play an important role for pharma and biotech companies. Under U.S. product liability law, significant liability can result “if a manufacturer or product seller fails to adequately communicate appropriate safety information to purchasers and users of its products”.
In the case Ramirez v. Plough, Inc., 25 Cal. Rptr.2d 97, 6 Cal. 4th 539 (Cal., 1993), Plaintiff brought a products liability action against Defendant, a non-prescription drug manufacturer. In the action, Plaintiff asserted he contracted Reye’s Syndrome as a result of ingesting one of Defendant’s nonprescription drugs. Plaintiff’s action was based on the fact the product’s mandatory warning label was printed only in English. At the time, Plaintiff was literate only in Spanish.
The court found for Defendant, concluding Plaintiff lacked sufficient grounds to bring a products liability case. According to the court’s reasoning, “A manufacturer may not be held liable in tort for failing to label a nonprescription drug with warnings in a language other than English.”
The court based its reasoning on a belief that tort liability should conform to state and federal law. Although both state and federal laws require English language warning labels for the particular drug in question, neither requires the warnings to be in any other language.
Thus, unless there is a state or federal statutory or administrative law requiring the use of foreign language warnings, an injured party has no grounds for a products liability claim against the manufacturer.